RxDoctor Payments Data

Kristina Colley, APRN

Family · Benton, KYNPI 1538821855

Payments from drug & device makers

$1,731in general payments, 2019–2025

Across 108 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$344
  • AbbVie$217
  • Axsome Therapeutics, Inc.$181
  • AstraZeneca$179
  • Pfizer$140
  • Lilly USA, LLC$102
  • plus $568 from 15 others

What the payments were for

  • Food & beverage$1,731100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,731 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$4,323
Medicare patients
58
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide50$54,353
MounjaroTirzepatide20$21,311
FarxigaDapagliflozin Propanediol15$20,647
Repatha SyringeEvolocumab24$10,855
Repatha SureclickEvolocumab11$9,264
Aripiprazole15$792
Gabapentin75$771
Atorvastatin Calcium136$730
Pantoprazole Sodium53$641
Buspirone Hcl43$590
Quetiapine Fumarate20$528
Levocetirizine Dihydrochloride31$476
Levothyroxine Sodium39$444
Ondansetron OdtOndansetron17$430
Testosterone Cypionate18$404

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$344$54,35350 claims
Lilly USA, LLCMounjaro$102$21,31120 claims
AstraZenecaFarxiga$179$20,64715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,374 family providers in Kentucky.

Other family in Benton

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →